Literature DB >> 21879286

Higher DNA repair activity is related with longer replicative life span in mammalian embryonic fibroblast cells.

Seong-Hoon Park1, Hong-Jun Kang, Hyun-Seok Kim, Min-Ju Kim, Jee-In Heo, Jeong-Hyeon Kim, Yoon-Jung Kho, Sung Chan Kim, Jaebong Kim, Jae-Bong Park, Jae-Yong Lee.   

Abstract

Since the detailed comparison of DNA repair activities among mammalian embryonic fibroblast cells with different replicative life spans has not been investigated, we tested DNA repair activities in embryonic fibroblast cells derived from mammals including human, dog, rat, and mouse. The cell viability after treatment of four DNA damage agents appeared to be decreased in the order of human embryonic fibroblasts (HEFs) > dog embryonic fibroblasts (DEFs) > rat embryonic fibroblasts (REFs) > mouse embryonic fibroblasts (MEFs) although statistical significance was lacking. The amounts of strand breaks and AP (apurinic/apyrimidinic) sites also appear to be decreased in the order of HEFs > DEFs > REFs ≥ MEFs after treatment of DNA damage agents. The DNA repair activities and rates including base excision repair (BER), nucleotide excision repair (NER) and double-strand break repair (DSBR) including non-homologous end-joining (NHEJ) decreased again in the order of HEFs > DEFs > REFs ≥ MEFs. BER and NHEJ activities in 3% O(2) also decreased in the order of HEFs > DEFs > REFs > MEFs. This order in DNA repair activity appears to be coincident with that of replicative life span of fibroblasts and that of life span of mammals. These results indicate that higher DNA repair activity is related with longer replicative life span in embryonic fibroblast cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21879286     DOI: 10.1007/s10522-011-9355-2

Source DB:  PubMed          Journal:  Biogerontology        ISSN: 1389-5729            Impact factor:   4.277


  6 in total

1.  mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases.

Authors:  Simon C Johnson; Frank Martinez; Alessandro Bitto; Brenda Gonzalez; Cagdas Tazaerslan; Camille Cohen; Laure Delaval; José Timsit; Bertrand Knebelmann; Fabiola Terzi; Tarika Mahal; Yizhou Zhu; Philip G Morgan; Margaret M Sedensky; Matt Kaeberlein; Christophe Legendre; Yousin Suh; Guillaume Canaud
Journal:  Kidney Int       Date:  2018-11-22       Impact factor: 10.612

2.  Dynamic In Vivo Profiling of DNA Damage and Repair after Radiotherapy Using Canine Patients as a Model.

Authors:  Nadine Schulz; Hassan Chaachouay; Katarzyna J Nytko; Mathias S Weyland; Malgorzata Roos; Rudolf M Füchslin; Franco Guscetti; Stephan Scheidegger; Carla Rohrer Bley
Journal:  Int J Mol Sci       Date:  2017-06-01       Impact factor: 5.923

Review 3.  Biogerontology: research status, challenges and opportunities.

Authors:  Suresh I S Rattan
Journal:  Acta Biomed       Date:  2018-06-07

Review 4.  DNA damage response proteins in canine cancer as potential research targets in comparative oncology.

Authors:  Beatriz Hernández-Suárez; David A Gillespie; Aleksandra Pawlak
Journal:  Vet Comp Oncol       Date:  2022-01-10       Impact factor: 2.385

5.  DNA damage response and DNA repair - dog as a model?

Authors:  Nicole Grosse; Barbara van Loon; Carla Rohrer Bley
Journal:  BMC Cancer       Date:  2014-03-19       Impact factor: 4.430

6.  A midlife crisis for the mitochondrial free radical theory of aging.

Authors:  Jeffrey A Stuart; Lucas A Maddalena; Max Merilovich; Ellen L Robb
Journal:  Longev Healthspan       Date:  2014-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.